Is your skin drier than usual
This regulatory milestone arrives as consumer search interest for weight loss medications often increases around the New Year period
Moreover, the SURMOUNTMMO (tirzepatide, NCT05556512) will assess the impact of the dual GLP-1/GIP RA in cardiovascular outcomes and all-cause mortality for people with obesity (without diabetes) when the REDEFINE-3 study will assess the impact of cagrisema in people with obesity (with and without T2DM) and established cardiovascular disease
Yes GLP-1 medications are prescription-only
[3] The MHRA and EMA continue to monitor the safety profile of semaglutide
Pharmacy Compounding Advisory Committee Meeting, December 4, 2024 vote on CJC-1295 (all five SKU variants: free base, acetate, DAC free base, DAC acetate, DAC trifluoroacetate) for 503A bulks-list inclusion